Gerrit Jansen Selected Research

Bortezomib (Velcade)

1/2021	Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells.
12/2017	(Immuno)proteasomes as therapeutic target in acute leukemia.
1/2017	Bortezomib resistance in multiple myeloma is associated with increased serine synthesis.
11/2016	Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors.
9/2015	ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2.
1/2015	Proteasome inhibitors as experimental therapeutics of autoimmune diseases.
1/2015	Molecular basis of resistance to proteasome inhibitors in hematological malignancies.
1/2015	Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis.
7/2014	Antileukemic activity and mechanism of drug resistance to the marine Salinispora tropica proteasome inhibitor salinosporamide A (Marizomib).
5/2014	Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerrit Jansen Research Topics

Disease

29	Neoplasms (Cancer) 04/2022 - 05/2003
26	Rheumatoid Arthritis 01/2022 - 07/2004
23	Leukemia 01/2021 - 01/2002
13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2020 - 01/2002
11	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2003
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 07/2011
7	Arthritis (Polyarthritis) 01/2022 - 03/2013
7	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 03/2013
7	Multiple Myeloma 12/2017 - 09/2008
6	Inflammation (Inflammations) 03/2019 - 11/2009
5	Heart Arrest (Cardiac Arrest) 01/2022 - 02/2012
5	Mesothelioma 01/2020 - 08/2003
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 11/2009
4	Carcinoma (Carcinomatosis) 05/2014 - 03/2003
4	Colonic Neoplasms (Colon Cancer) 12/2011 - 08/2003
3	Carcinogenesis 12/2020 - 08/2013
3	Lung Neoplasms (Lung Cancer) 04/2014 - 08/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012 - 08/2003
2	Fistula 10/2021 - 10/2021
2	Sepsis (Septicemia) 10/2021 - 01/2021
2	Lymphoma (Lymphomas) 01/2020 - 04/2016
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 02/2016
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 01/2015
2	Synovitis 03/2014 - 03/2013
2	Colorectal Neoplasms (Colorectal Cancer) 12/2011 - 06/2007
2	Hereditary Folate Malabsorption 08/2009 - 09/2008
2	T-Cell Leukemia (Leukemia, T Cell) 04/2009 - 07/2008
2	Hypersensitivity (Allergy) 02/2003 - 02/2003
1	Out-of-Hospital Cardiac Arrest 12/2021
1	COVID-19 12/2021
1	Hemorrhage 10/2021

Drug/Important Bio-Agent (IBA)

29	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 01/2002
29	Methotrexate (Mexate)FDA LinkGeneric 10/2021 - 01/2002
22	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2003
19	Pharmaceutical PreparationsIBA 12/2020 - 01/2002
18	Bortezomib (Velcade)FDA Link 01/2021 - 09/2008
16	Proteasome InhibitorsIBA 01/2021 - 09/2008
12	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 07/2010
12	multidrug resistance-associated protein 1IBA 01/2019 - 02/2003
10	Folic Acid AntagonistsIBA 01/2021 - 01/2002
6	folylpolyglutamate synthetaseIBA 01/2021 - 02/2003
6	EnzymesIBA 10/2019 - 02/2003
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 02/2003
5	Pemetrexed (MTA)FDA Link 01/2021 - 01/2002
5	Thymidylate SynthaseIBA 01/2019 - 01/2002
5	Messenger RNA (mRNA)IBA 11/2016 - 08/2003
4	poly(ethylene glycol)-folateIBA 01/2020 - 03/2013
3	NucleotidesIBA 04/2022 - 04/2009
3	Amino Acids FDA Link 04/2022 - 08/2009
3	Folate Receptor 2IBA 01/2022 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
3	RNA Precursors (Precursor, mRNA)IBA 01/2021 - 05/2015
3	GlucocorticoidsIBA 03/2020 - 10/2007
3	Proton-Coupled Folate TransporterIBA 01/2020 - 09/2008
3	Biological ProductsIBA 10/2019 - 01/2015
3	LigandsIBA 01/2019 - 03/2013
3	Adenosine Triphosphate (ATP)IBA 01/2019 - 01/2007
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019 - 06/2004
3	AminopeptidasesIBA 01/2018 - 04/2014
3	UbiquitinIBA 01/2018 - 08/2013
3	methylated bovine serum albumin (MBSA)IBA 01/2018 - 03/2014
3	carfilzomibIBA 01/2014 - 04/2012
3	Leucovorin (Folinic Acid)FDA Link 12/2011 - 02/2003
3	7-hydroxymethotrexateIBA 04/2009 - 12/2004
3	Reduced Folate Carrier ProteinIBA 04/2006 - 02/2004
2	Oxygen (Dioxygen)IBA 04/2022 - 12/2021
2	CarbonIBA 01/2021 - 03/2019
2	RNA Splicing FactorsIBA 12/2020 - 05/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 12/2013
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2020
2	AntibodiesIBA 01/2018 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 02/2004
2	ProdrugsIBA 02/2016 - 04/2014
2	Rituximab (Mabthera)FDA Link 03/2015 - 01/2013
2	Antirheumatic Agents (DMARD)IBA 01/2015 - 04/2012
2	CytokinesIBA 01/2015 - 07/2011
2	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2015 - 03/2013
2	PR-957IBA 01/2014 - 12/2013
2	Ligases (Synthetase)IBA 08/2013 - 04/2009
2	Fluorouracil (Carac)FDA LinkGeneric 12/2011 - 06/2007
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2007 - 06/2004
2	N(alpha)- (4- amino- 4- deoxypteroyl)- N(delta)- hemiphthaloyl- L- ornithine (PT 523)IBA 04/2006 - 01/2002
1	NAD (NADH)IBA 04/2022
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2022
1	allogenic effect factor (AEF)IBA 10/2021
1	CatecholaminesIBA 10/2021
1	Thiamine (Aneurin)FDA Link 01/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021
1	ethyl 2- (5- (4- chlorophenyl)pentyl)oxiran- 2- carboxylate (POCA)IBA 01/2021
1	Lipopolysaccharide ReceptorsIBA 01/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2021

Therapy/Procedure

23	Therapeutics 01/2022 - 07/2004
8	Drug Therapy (Chemotherapy) 01/2021 - 12/2006
3	Combination Drug Therapy (Combination Chemotherapy) 04/2014 - 02/2004
2	Resuscitation 12/2021 - 04/2020
1	Continuous Renal Replacement Therapy 01/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Airway Management 12/2021
1	Advanced Cardiac Life Support (Life Support, Advanced Cardiac) 12/2021
1	Emergency Treatment 10/2021